RAPT Therapeutics (RAPT) Competitors $1.07 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RAPT vs. BDTX, NLTX, IVA, ABOS, ELUT, FTLF, IXHL, SGMT, CRDL, and PBYIShould you be buying RAPT Therapeutics stock or one of its competitors? The main competitors of RAPT Therapeutics include Black Diamond Therapeutics (BDTX), Neoleukin Therapeutics (NLTX), Inventiva (IVA), Acumen Pharmaceuticals (ABOS), Elutia (ELUT), FitLife Brands (FTLF), Incannex Healthcare (IXHL), Sagimet Biosciences (SGMT), Cardiol Therapeutics (CRDL), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical products" industry. RAPT Therapeutics vs. Black Diamond Therapeutics Neoleukin Therapeutics Inventiva Acumen Pharmaceuticals Elutia FitLife Brands Incannex Healthcare Sagimet Biosciences Cardiol Therapeutics Puma Biotechnology RAPT Therapeutics (NASDAQ:RAPT) and Black Diamond Therapeutics (NASDAQ:BDTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Does the media favor RAPT or BDTX? In the previous week, RAPT Therapeutics had 8 more articles in the media than Black Diamond Therapeutics. MarketBeat recorded 9 mentions for RAPT Therapeutics and 1 mentions for Black Diamond Therapeutics. Black Diamond Therapeutics' average media sentiment score of 1.92 beat RAPT Therapeutics' score of 0.52 indicating that Black Diamond Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RAPT Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Black Diamond Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals believe in RAPT or BDTX? 99.1% of RAPT Therapeutics shares are held by institutional investors. Comparatively, 95.5% of Black Diamond Therapeutics shares are held by institutional investors. 6.6% of RAPT Therapeutics shares are held by company insiders. Comparatively, 8.9% of Black Diamond Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, RAPT or BDTX? RAPT Therapeutics has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, Black Diamond Therapeutics has a beta of 2.51, indicating that its share price is 151% more volatile than the S&P 500. Do analysts recommend RAPT or BDTX? RAPT Therapeutics presently has a consensus target price of $9.50, indicating a potential upside of 787.85%. Black Diamond Therapeutics has a consensus target price of $15.50, indicating a potential upside of 537.86%. Given RAPT Therapeutics' higher probable upside, analysts clearly believe RAPT Therapeutics is more favorable than Black Diamond Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RAPT Therapeutics 1 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.08Black Diamond Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in RAPT or BDTX? RAPT Therapeutics received 38 more outperform votes than Black Diamond Therapeutics when rated by MarketBeat users. However, 69.86% of users gave Black Diamond Therapeutics an outperform vote while only 63.12% of users gave RAPT Therapeutics an outperform vote. CompanyUnderperformOutperformRAPT TherapeuticsOutperform Votes8963.12% Underperform Votes5236.88% Black Diamond TherapeuticsOutperform Votes5169.86% Underperform Votes2230.14% Is RAPT or BDTX more profitable? Black Diamond Therapeutics' return on equity of -68.08% beat RAPT Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets RAPT TherapeuticsN/A -89.10% -76.13% Black Diamond Therapeutics N/A -68.08%-49.65% Which has preferable earnings & valuation, RAPT or BDTX? Black Diamond Therapeutics has lower revenue, but higher earnings than RAPT Therapeutics. Black Diamond Therapeutics is trading at a lower price-to-earnings ratio than RAPT Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRAPT Therapeutics$1.53M24.45-$116.80M-$2.77-0.39Black Diamond TherapeuticsN/AN/A-$82.44M-$1.33-1.83 SummaryBlack Diamond Therapeutics beats RAPT Therapeutics on 10 of the 16 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get RAPT Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RAPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RAPT vs. The Competition Export to ExcelMetricRAPT TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.41M$6.45B$5.06B$8.82BDividend YieldN/A8.11%5.18%4.07%P/E Ratio-0.3910.78126.3117.81Price / Sales24.45243.711,178.7474.57Price / CashN/A22.1633.8632.53Price / Book0.255.474.684.68Net Income-$116.80M$153.61M$119.54M$226.08M7 Day Performance-16.41%-2.00%-1.83%-1.04%1 Month Performance-34.95%-7.46%-3.60%1.04%1 Year Performance-92.14%31.82%31.91%26.28% RAPT Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RAPTRAPT Therapeutics4.5981 of 5 stars$1.07flat$9.50+787.9%-92.3%$37.40M$1.53M-0.3980BDTXBlack Diamond Therapeutics2.8436 of 5 stars$2.43-4.7%$15.50+537.9%+8.0%$144.29MN/A0.0090Positive NewsNLTXNeoleukin TherapeuticsN/A$15.33-11.0%N/A+30.5%$144.07MN/A-4.9390High Trading VolumeIVAInventiva3.0751 of 5 stars$2.74flat$14.00+410.9%-31.9%$143.79M$18.91M0.00100News CoverageABOSAcumen Pharmaceuticals2.6635 of 5 stars$2.37-0.8%$9.00+279.7%+0.4%$143.59MN/A0.0051Analyst RevisionELUTElutia2.685 of 5 stars$4.38+4.0%$10.00+128.3%+170.4%$143.39M$24.75M0.00180FTLFFitLife Brands4.0645 of 5 stars$31.83+2.3%$40.00+25.7%+59.9%$143.01M$52.70M18.8320Analyst RevisionIXHLIncannex Healthcare1.3552 of 5 stars$2.09-2.8%N/A+132.2%$136.48M$10,000.000.003Gap UpSGMTSagimet Biosciences2.1861 of 5 stars$4.52+2.5%$21.60+377.9%+50.2%$135.28M$2M0.008CRDLCardiol Therapeutics2.7365 of 5 stars$1.56-5.5%$8.75+460.9%+81.1%$134.65M$60,000.00-4.0020Analyst ForecastAnalyst RevisionNews CoveragePBYIPuma Biotechnology4.4141 of 5 stars$2.84+3.6%$7.00+146.5%-27.0%$134.50M$235.60M5.92185Analyst ForecastPositive News Related Companies and Tools Related Companies Black Diamond Therapeutics Competitors Neoleukin Therapeutics Competitors Inventiva Competitors Acumen Pharmaceuticals Competitors Elutia Competitors FitLife Brands Competitors Incannex Healthcare Competitors Sagimet Biosciences Competitors Cardiol Therapeutics Competitors Puma Biotechnology Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RAPT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RAPT Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAPT Stock Alerts